Segment Report |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Segment Report [Abstract] | |
| Segment Report | Note 9 – Segment Report
The Company’s Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment – developing products that use mRNA genetic biomarkers to potentially assess the occurrence of inflammation, and, as a result, inflammation related chronic diseases. Within this segment, the Company’s products will be sold into the medical markets.
The Company’s CEO assesses performance and decides how to allocate resources primarily based on consolidated net income, which is reported on the Company’s Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|